Login / Signup

Elevated expression of serum soluble ST2 in clinical relapse after stopping long-term Nucleos(t)ide analogue therapy for chronic hepatitis B.

Linqing XieGuichan LiaoHongjie ChenMuye XiaXuan HuangRong FanJie PengXiaoyong ZhangHongyan Liu
Published in: BMC infectious diseases (2019)
The trial was retrospectively registered at Chinese Clinical Trial Registry: ChiCTR-OOC-17013970 . Registration date: December 15, 2017.
Keyphrases
  • clinical trial
  • phase ii
  • phase iii
  • study protocol
  • poor prognosis
  • hepatitis b virus
  • open label
  • double blind
  • randomized controlled trial
  • liver fibrosis
  • free survival
  • long non coding rna